Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-03-005637
Filing Date
2003-05-09
Accepted
2003-05-09 16:32:49
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 HALSEY DRUG CO., INC. y85411e10vk.txt 10-K 332911
3 CONSENT OF GRANT THORNTON LLP y85411exv23w1.txt EX-23.1 760
4 CERTIFICATION OF PERIODIC REPORT BY CEO y85411exv99w1.txt EX-99.1 3785
5 CERTIFICATION OF PERIODIC REPORT BY CFO y85411exv99w2.txt EX-99.2 3772
6 CERTIFICATION OF CEO y85411exv99w3.txt EX-99.3 1072
7 CERTIFICATION OF CFO y85411exv99w4.txt EX-99.4 1161
  Complete submission text file 0000950123-03-005637.txt   345611
Mailing Address 695 N. PERRYVILLE ROAD ROCKFORD IL 61107
Business Address 1827 PACIFIC ST BROOKLYN NY 11233 7184677500
HALSEY DRUG CO INC/NEW (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 03690714
SIC: 2834 Pharmaceutical Preparations